Coronary revascularisation outcome questionnaire: validation study of the Serbian version

被引:0
作者
Nemanja Aleksic
Svetozar Putnik
Sara Schroter
Vedrana Pavlovic
Uros Bumbasirevic
Mina Zlatkovic
Ilija Bilbija
Milos Matkovic
Aleksa Jovanovic
Tatjana Pekmezovic
Gorica Maric
机构
[1] University Clinical Center of Serbia,Clinic for Cardiac Surgery
[2] BMA House,Institute for Medical Statistics and Informatics, Faculty of Medicine
[3] University of Belgrade,Clinic for Urology
[4] University Clinical Center of Serbia,Institute of Epidemiology, Faculty of Medicine
[5] University of Belgrade,undefined
来源
Quality of Life Research | 2022年 / 31卷
关键词
Ischaemic heart disease; Health-related quality of life; Patient-reported outcome measure; Coronary artery bypass surgery; Percutaneous coronary intervention;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1883 / 1895
页数:12
相关论文
共 207 条
[1]  
Moran AE(2014)The global burden of ischemic heart disease in 1990 and 2010: The global burden of disease 2010 study Circulation 129 1493-1501
[2]  
Forouzanfar MH(2017)Ischaemic heart disease mortality in Serbia, 1991–2013; a joinpoint analysis Indian Journal of Medical Research 146 746-753
[3]  
Roth G(2020)Global epidemiology of ischemic heart disease: Results from the global burden of disease study Cureus 12 2541-2619
[4]  
Mensah GA(2014)2014 ESC/EACTS guidelines on myocardial revascularisation: The task force on myocardial revascularisation of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) European Heart Journal 35 1325-1334
[5]  
Ezzati M(2019)Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial Lancet 394 1930-1941
[6]  
Flaxman A(2019)Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: An analysis from the EXCEL trial European Heart Journal 40 191-199
[7]  
Murray CJL(2020)Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: Updated 5-year outcomes from the randomised, non-inferiority NOBLE trial Lancet 395 42-658
[8]  
Naghavi M(2003)Quality of life in patients with coronary heart disease-I: Assessment tools Health and Quality of Life Outcomes 1 7842514-160
[9]  
Ilic M(2016)Comparison of the postprocedural quality of life between coronary artery bypass graft surgery and percutaneous coronary intervention: A systematic review Cardiology Research and Practice 2016 653-2120
[10]  
Ilic I(1999)Quality of life after coronary angioplasty or bypass surgery. 1-year follow-up in the coronary angioplasty versus Bypass Revascularization investigation (CABRI) trial European Heart Journal 20 152-773